You are viewing the site in preview mode

Skip to main content
Fig. 6 | BMC Infectious Diseases

Fig. 6

From: Designing a multi-epitope universal vaccine for concurrent infections of SARS-CoV-2 and influenza viruses using an immunoinformatics approach

Fig. 6

Docking and self-docking results. (A) Docking analysis between the vaccine construct (ligand) and TLR-3 (receptor). (B) Identification of interacting residues between the vaccine and TLR-3. (C) and (D) Stages of self-docking; (C) Structure of 3ULV (the crystal structure of human TLR-3 in complex with its ligand). (D) The specific ligand of 3ULV (green) docked with its receptor in the correct orientation

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us